Buyer	UK Health Security Agency — not a council we hold
Supplier	GlaxoSmithKline UK Limited

A contract for the supply of DTaP/IPV/Hib+HepB vaccine, to be used as part of the national childhood immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.

Runs	1 Apr 2025 to 31 Mar 2029
OCID	ocds-b5fd17-78a97b4a-0969-4395-9aa2-7b0b9f9df6c4
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.